Stomach Cancer Trial Results
- Chemotherapy Before Surgery May Increase Survival in Stomach Cancer
(Posted: 07/09/2007, Updated: 10/19/2011) - Chemotherapy given before surgery for cancer of the lower esophagus and stomach increased the number of patients surviving for five years compared to surgery alone, according to findings presented at the 2007 ASCO meeting in Chicago.
- Breast Cancer Drug Helps Patients with Gastric Cancer
(Posted: 06/19/2009, Updated: 10/01/2010) - Patients with advanced gastric cancer who received standard chemotherapy plus trastuzumab (Herceptin®) survived several months longer than those who received chemotherapy alone, according to findings presented at the 2009 ASCO meeting in Orlando.
- Eliminating a Common Bacterium Reduces Risk of Second Gastric Cancer
(Posted: 09/02/2008) - When the bacterium Helicobacter pylori is eliminated in patients who are treated for early stage gastric cancer, the risk of developing a second gastric cancer decreases by two-thirds, according to the Aug. 2, 2008, issue of The Lancet.
- Stomach Cancer Drug, S-1, Shows Promise in Japanese Trial
(Posted: 03/12/2008) - In this Japanese clinical trial, patients with advanced, inoperable stomach cancer who received combination therapy with cisplatin and a drug called S-1 lived about two months longer than patients treated with S-1 alone, according to the March 2008 Lancet Oncology.
- New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer
(Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.